Browse drugs

…Background To investigate the impact of ITGBL1 on 5-fluorouracil (5-FU) sensitivity in colorectal cancer and explore its underly…

…ypically delivered 5 days a week over 7 weeks concurrently with cisplatin, a regimen established through multiple randomised trials, demo…

…assay for measuring the concentration and physical stability of 5-fluorouracil (5-FU) at standardised rounded doses in polyolefin (POF) infusi…

… HCT116 cells treated with Ri plus chemotherapy (5-FU 40 mg/kg; oxaliplatin 7.5 mg/kg). Tumour burden, tumour multiplicity, and apoptosis (…

…is. Clinical relevance was assessed in GC patients treated with 5-fluorouracil (5-FU) monotherapy and those receiving combination 5-FU plus an…

…ducted, no agents have received approval, with the exception of valrubicin, largely attributed to factors such as the varied prior BCG exp…

…of bacterial gene families associated with proteins involved in 5-fluorouracil (5-FU) metabolism, such as uridine monophosphate kinase (logFC …

… did not respect prescribed doses – for example, when a dose of 5-FU 609 mg was prescribed, only 600 mg was prepared to avoid openin…

… with clinical outcomes ( figure 1). The PDTOs are sensitive to 5-FU, oxaliplatin, irinotecan and their combination (figure 2). Howe…